Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
NCT06517186
This study is recruiting at 6 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treatments for heart failure.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Heart Failure
- Heart Failure With Preserved Ejection Fraction
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 30 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Northwestern University
- Last updated on ClinicalTrials.gov
- September 29, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Northwestern University · Chicago, IL
Maryland · 1
- Johns Hopkins University · Baltimore, MD
Massachusetts · 1
- Mass General Brigham · Boston, MA
Minnesota · 1
- Mayo Clinic · Rochester, MN
North Carolina · 1
- Wake Forest University · Winston-Salem, NC
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.